Triple therapy in type 2 diabetes: Insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naïve patients

Diabetes Care

Volumn 29, Issue 3, 2006, Pages 554-559

  Rosenstock, Julio ^a   Sugimoto, Danny ^b   Strange, Poul ^c   Stewart, John A ^d   Soltes Rak, Erika ^c   Dailey, George ^e  

^a DALLAS DIABETES AND ENDOCRINE CENTER AT MEDICAL CITY   (United States)

^b Cedar Crosse Research Center   (United States)

^c SANOFI   (France)

^d Sanofi Avenus Pharmaceuticals   (Canada)

^e SCRIPPS CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INSULIN GLARGINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ROSIGLITAZONE; SULFONYLUREA; TRIACYLGLYCEROL; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; DRUG DERIVATIVE; GLARGINE; GLYCOSYLATED HEMOGLOBIN; LIPID; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG OVERDOSE; DRUG SAFETY; EDEMA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; IRON DEFICIENCY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL EDEMA; RANDOMIZED CONTROLLED TRIAL; TUMOR; VOMITING; WEIGHT GAIN; BLOOD; DRUG COMBINATION; ECONOMICS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LIPIDS; MALE; METFORMIN; MIDDLE AGED; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 33745000699     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/diacare.29.03.06.dc05-0695     Document Type: Article

References (23)

1. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO: Glycemic control from 1988 to 2000 among U.S. adults diagnosed with type 2 diabetes. Diabetes Care 27:17-20, 2004
2. Turner RC, Cull CA, Frighi V, Holman RR, UK Prospective Diabetes Study (UKPDS) Group: Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 281:2005-2012, 1999
3. Wright A, Burden AC, Paisey RB, Cull CA, Holman RR, the U.K. Prospective Diabetes Study Group: Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 25:330 -336, 2002
4. Brown JB, Nichols GA, Perry A: The burden of treatment failure in type 2 diabetes. Diabetes Care 27:1535-1540, 2004
5. Inzucchi SE: Oral antihyperglycemic therapy for type 2 diabetes. JAMA 287:360-372, 2002
6. Yale JF, Valiquett TR, Ghazzi MN, Owens-Grillo JK, Whitcomb RW, Foyt HL: The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin; a multicenter, randomized, double-blind, placebo-controlled trial. Ann Intern Med 134:737-745, 2001
7. Dailey GE, Noor MA, Park J, Bruce S, Fiedorek FT: Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial. Am J Med 116:223-229, 2004
8. Schwartz S, Sievers R, Strange P, Lyness WH, Hollander P, INS-2061 Study Team: Insulin 70/30 mix plus metformin versus triple oral therapy in the treatment of type 2 diabetes after failure of two oral drugs: efficacy, safety, and cost analysis. Diabetes Care 26:2238-2243, 2003
9. Riddle MC, Rosenstock J, Gerich J: The Treat-to-Target Trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care 26:3080-3086, 2003
10. Cohen H (Ed.): 2002 Drug Topics Redbook. Montvale, NJ, Medical Economics, 2002
11. The Essential RBRVS. Gray L, Ed. Salt Lake City, UT, Ingenix, 2002
12. Davidson MB: Triple therapy: definitions, application, and treating to target (Editorial). Diabetes Care 27:1834-1835, 2004
13. Ahmann A, Riddle MC: What to do when two oral agents fail to control type 2 diabetes: a matter of opinion or a matter of fact? Am J Med 116:276-278, 2004
14. Aljabri K, Kozak S, Thompson DM: Addition of pioglitazone or bedtime insulin to maximal doses of sulphonylurea and metformin in type 2 diabetes patients with poor glucose control: a prospective, randomized trial. Am J Med 116:230-235, 2004
15. Rosenstock J, Wyne K: Insulin treatment in type 2 diabetes. In Textbook of Type 2 Diabetes. Goldstein BJ, Muller-Wieland D, Eds. London, Martin Dinitz, 2003, p. 131-154
16. Fonseca V: Effect of thiazolidinediones on body weight in patients with diabetes mellitus. Am J Med 115 (Suppl. 8A):42S-48S, 200
17. Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS: Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in type II diabetes mellitus. Arch Intern Med 158:2485-2490, 1998
18. Lewis GF, Steiner G: Acute effects of insulin in the control of VLDL production in humans: implications for the insulin-resistant state. Diabetes Care 19:390-393, 1996
19. Cusi K, Cunningham GR, Comstock JP: Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care 18:843- 851, 1995
20. Taskinen MR, Kuusi T, Helve E, Nikkila EA, Yki-Jarvinen H: Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 8:168-177, 1988
21. Gilmer TP, O'Connor PJ, Manning WG, Rush WA: The cost to health plans of poor glycemic control. Diabetes Care 20:1847-1853, 1997
22. Wagner EH, Sandhu M, Newton K, Mc-Culloch DK, Ramsey SD, Grothaus LC: Effect of improved glycemic control on health care costs and utilization. JAMA 285:182-189, 2001
23. Menzin J, Langley-Hawthorne C, Friedman M, Boulanger L, Cavanaugh R: Potential short-term economic benefits of improved glycemic control: a managed care perspective. Diabetes Care 24:51-55, 2001